Inovio Pharmaceuticals, Inc. (INO)
Last updated: 2026-10-21 20:50:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Inovio Pharmaceuticals, Inc. (INO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.80, with a market capitalization of $103.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.56 to $2.72. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$103.40M | |
$1.06 | |
$405.48 | |
$0.56 | |
$1.01 | |
11.09M | |
4.30M | |
-- | |
$2.72 | |
$0.56 | |
-- | |
-- |
Inovio Pharmaceuticals, Inc. (INO) After-Hours Stock Price
Inovio Pharmaceuticals, Inc. (INO) is trading at $0.79 in after-hours trading as of 2026-10-21 20:48:00, down 22.28% ($0.22) from the regular-session close of $1.01.
After-hours trading shows how investors are pricing INO after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Inovio Pharmaceuticals, Inc. (INO) 7-Day Stock Price Change
Over the past seven days, Inovio Pharmaceuticals, Inc. (INO) moved from $1.11 to $0.80, representing a decline of 27.51% ($0.30).
The stock traded between $0.80 and $1.18 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 4.37 million shares, up versus the previous seven-day period, indicating higher trading activity.
INO 52-Week Price Position
Position in Range: 11.0%
INO is currently trading at $0.80, placing it 11.0% of the way from its 52-week low of $0.56 to its 52-week high of $2.72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Inovio Pharmaceuticals, Inc. (INO)?
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.
Inovio Pharmaceuticals, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 112 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Inovio Pharmaceuticals, Inc. (INO) Stock on MEXC
Eligible investors can buy real shares of Inovio Pharmaceuticals, Inc. (INO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Inovio Pharmaceuticals, Inc. (INO) stock price today?
2.Is INO stock going up or down today?
3.What is INO pre-market price?
4.What is INO after-hours price?
5.Is INO stock trading now?
6.Where does INO sit relative to its 52-week high and low?
7.What sector is Inovio Pharmaceuticals, Inc. in?
8.What is Inovio Pharmaceuticals, Inc.'s market capitalization and where is it listed?
9.How is INO valued in terms of P/E ratio and EPS?
10.Does Inovio Pharmaceuticals, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
INO Stock Calculator
Estimate the value between INO shares and USD.
INO Shares to USD
1.00 INO shares = 0.801 USD
Calculations are estimates based on the latest available price and are for reference only.


